Related references
Note: Only part of the references are listed.The absence of curly hair is associated with a milder phenotype in Giant Axonal Neuropathy
Lisa A. Roth et al.
NEUROMUSCULAR DISORDERS (2014)
A novel mutation in the GAN gene causes an intermediate form of giant axonal neuropathy in an Arab-Israeli family
M. Abu-Rashid et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2013)
Restoration of Cytoskeleton Homeostasis After Gigaxonin Gene Transfer for Giant Axonal Neuropathy
Silke Mussche et al.
HUMAN GENE THERAPY (2013)
Giant Axonal Neuropathy Caused by a Novel Compound Heterozygous Mutation in the Gigaxonin Gene
Min Xu et al.
JOURNAL OF CHILD NEUROLOGY (2013)
Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation
Saleemulla Mahammad et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Clinicogenetical features of a Japanese patient with giant axonal neuropathy
Motohiro Akagi et al.
BRAIN & DEVELOPMENT (2012)
Genetic axonal neuropathies and neuronopathies of pre-natal and infantile onset
Eppie M. Yiu et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2012)
PROTEOMIC ANALYSIS IN GIANT AXONAL NEUROPATHY: NEW INSIGHTS INTO DISEASE MECHANISMS
Silke Mussche et al.
MUSCLE & NERVE (2012)
HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease
Constantin d'Ydewalle et al.
NATURE MEDICINE (2011)
Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
Marco A. Passini et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Dynamics of Cullin-RING Ubiquitin Ligase Network Revealed by Systematic Quantitative Proteomics
Eric J. Bennett et al.
CELL (2010)
Giant Axonal Neuropathy with Predominant Central Nervous System Manifestations
Yair Lampl et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2010)
HDAC6 Regulates Mitochondrial Transport in Hippocampal Neurons
Sigeng Chen et al.
PLOS ONE (2010)
Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway
Don W. Cleveland et al.
HUMAN MOLECULAR GENETICS (2009)
Clinical and Genetic Studies in a Chinese Family With Giant Axonal Neuropathy
Li-Ping Zhang et al.
JOURNAL OF CHILD NEUROLOGY (2009)
Dysfunctions of neuronal and glial intermediate filaments in disease
Ronald K. H. Liem et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Phenotypic variability in giant axonal neuropathy
Meriem Tazir et al.
NEUROMUSCULAR DISORDERS (2009)
Clinical, pathological and molecular findings in two siblings with giant axonal neuropathy (GAN): Report from India
A. Nalini et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2008)
New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy
Henry Houlden et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Genotype-phenotype analysis in patients with giant axonal neuropathy (GAN)
Olga Koop et al.
NEUROMUSCULAR DISORDERS (2007)
Giant axonal neuropathy
Y. Yang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Alterations in lipid metabolism gene expression and abnormal lipid accumulation in fibroblast explants from giant axonal neuropathy patients
Conrad L. Leung et al.
BMC GENETICS (2007)
Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton
Gian Maria Fabrizi et al.
BRAIN (2007)
CNS immune privilege: hiding in plain sight
Monica J. Carson et al.
IMMUNOLOGICAL REVIEWS (2006)
Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport
JQ Ding et al.
HUMAN MOLECULAR GENETICS (2006)
Gigaxonin interacts with tubulin folding cofactor B and controls its degradation through the ubiquitin-proteasome pathway
W Wang et al.
CURRENT BIOLOGY (2005)
Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival
E Allen et al.
NATURE (2005)
Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway
DD Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E
GM Fabrizi et al.
NEUROLOGY (2004)
Clinical and molecular findings in patients with giant axonal neuropathy (GAN)
C Bruno et al.
NEUROLOGY (2004)
The cytoskeleton in neurodegenerative diseases
NJ Cairns et al.
JOURNAL OF PATHOLOGY (2004)
Functions of intermediate filaments in neuronal development and disease
RC Lariviere et al.
JOURNAL OF NEUROBIOLOGY (2004)
Intermediate filament aggregation in fibroblasts of giant axonal neuropathy patients is aggravated in non dividing cells and by microtubule destabilization
P Bomont et al.
HUMAN MOLECULAR GENETICS (2003)
Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases
M Furukawa et al.
NATURE CELL BIOLOGY (2003)
Genetic heterogeneity in giant axonal neuropathy: an Algerian family not linked to chromosome 16q24.1
M Tazir et al.
NEUROMUSCULAR DISORDERS (2002)
Microtubule-associated protein 1B: a neuronal binding partner for gigaxonin
JQ Ding et al.
JOURNAL OF CELL BIOLOGY (2002)
The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy
P Bomont et al.
NATURE GENETICS (2000)
The Raf-1 kinase associates with vimentin kinases and regulates the structure of vimentin filaments
P Janosch et al.
FASEB JOURNAL (2000)
Share Paper
